The cost-effectiveness analysis of a nationwide vitamin D supplementation program among Iranian adolescents for adulthood cardiovascular diseases prevention.


Journal

Public health
ISSN: 1476-5616
Titre abrégé: Public Health
Pays: Netherlands
ID NLM: 0376507

Informations de publication

Date de publication:
Sep 2021
Historique:
received: 21 03 2021
revised: 18 06 2021
accepted: 17 07 2021
pubmed: 13 9 2021
medline: 30 9 2021
entrez: 12 9 2021
Statut: ppublish

Résumé

This study aimed to evaluate a national vitamin D supplementation program's cost-effectiveness among Iranian adolescents to prevent cardiovascular diseases (CVDs) in adulthood. A cost-effectiveness analytical study. A decision tree model was adopted to evaluate the cost per quality-adjusted life-year (QALY) of monthly intake of nine pearls of 50,000 IU vitamin D for nine months to prevent CVD a one-year horizon compared to no intervention. The analysis was conducted in Iranian adolescents in first or second high school grades of 47 climatically different Iran regions. Our analytical analysis estimated the 1090$ cost per QALY gained of the monthly intake of 50,000 IU vitamin D for nine months among adolescents over a one-year horizon. Based on the incremental cost-effectiveness ratio (ICER) threshold of 1032-2666, vitamin D supplementation was cost-effective for adolescents to prevent adulthood CVD. It means that vitamin D supplementation costs were substantially less than the costs of CVD treatments compared to the no intervention. Based on these findings, the national program of vitamin D supplementation in adolescents would be cost effective to prevent CVD development in adulthood. From an economic perspective, vitamin D supplementation, especially in adolescents with vitamin D deficiency, would be administrated.

Identifiants

pubmed: 34509859
pii: S0033-3506(21)00288-2
doi: 10.1016/j.puhe.2021.07.019
pii:
doi:

Substances chimiques

Vitamin D 1406-16-2

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

340-347

Informations de copyright

Copyright © 2021 The Royal Society for Public Health. Published by Elsevier Ltd. All rights reserved.

Auteurs

Narges Zandieh (N)

Faculty of Pharmacy, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran. Electronic address: narges.zandieh@yahoo.com.

Mohsen Rezaei Hemami (M)

University of Aberdeen, Aberdeen Centre for Health Data Sciences, Southampton, UK.

Ali Darvishi (A)

Department of Management and Health Economics, School of Public Health, Tehran University of Medical Sciences (TUMS), Tehran, Iran.

Seyed Mohammad Hasheminejad (SM)

Department of Management, Medical Science Branch, Islamic Azad University, Tehran, Iran.

Zahra Abdollahi (Z)

Office of Community Nutrition, Deputy of Health, Iran Ministry of Health and Medical Education.

Maryam Zarei (M)

Office of Community Nutrition, Deputy of Health, Iran Ministry of Health and Medical Education.

Ramin Heshmat (R)

Chronic Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: rheshmat@tums.ac.ir.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH